These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26701717)

  • 1. Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer.
    Doddapaneni R; Patel K; Owaid IH; Singh M
    Drug Deliv; 2016 May; 23(4):1232-41. PubMed ID: 26701717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer.
    Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F
    Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A solvent-assisted active loading technology to prepare gambogic acid and all-trans retinoic acid co-encapsulated liposomes for synergistic anticancer therapy.
    Na K; Liu K; Yu J; Wang X; Li M; Tian C; He H; He Y; Wang Y
    Drug Deliv Transl Res; 2020 Feb; 10(1):146-158. PubMed ID: 31529371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer.
    Saxena V; Hussain MD
    Int J Nanomedicine; 2012; 7():713-21. PubMed ID: 22359450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
    Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
    Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment.
    Huang R; Li J; Kebebe D; Wu Y; Zhang B; Liu Z
    Drug Deliv; 2018 Nov; 25(1):757-765. PubMed ID: 29528244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 targeted redox-triggered self-assembly with magnetic enhanced EPR effects for effective amplification of gambogic acid to treat triple-negative breast cancer.
    Sang M; Han L; Luo R; Qu W; Zheng F; Zhang K; Liu F; Xue J; Liu W; Feng F
    Biomater Sci; 2019 Dec; 8(1):212-223. PubMed ID: 31674634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells.
    Li C; Qi Q; Lu N; Dai Q; Li F; Wang X; You Q; Guo Q
    Biochem Cell Biol; 2012 Dec; 90(6):718-30. PubMed ID: 23194187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
    Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J
    Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and development of PEGylated liposomal formulation of HER2 blocker Lapatinib for enhanced anticancer activity and diminished cardiotoxicity.
    Shrivastava R; Trivedi S; Singh PK; Asif M; Chourasia MK; Khanna A; Bhadauria S
    Biochem Biophys Res Commun; 2018 Sep; 503(2):677-683. PubMed ID: 29908185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance.
    Wang S; Yang Y; Wang Y; Chen M
    Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
    Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
    J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Yang R; Lu M; Ming L; Chen Y; Cheng K; Zhou J; Jiang S; Lin Z; Chen D
    Int J Nanomedicine; 2020; 15():9061-9074. PubMed ID: 33239874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG-coated irinotecan cationic liposomes improve the therapeutic efficacy of breast cancer in animals.
    Zhang L; Cao DY; Wang J; Xiang B; Dun JN; Fang Y; Xue GQ
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3347-61. PubMed ID: 24379067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line.
    Sandal P; Patel P; Singh D; Gupta GD; Kurmi BD
    Assay Drug Dev Technol; 2023; 21(8):345-356. PubMed ID: 38010987
    [No Abstract]   [Full Text] [Related]  

  • 17. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
    Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
    Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect and metabolic fingerprinting of triple-negative breast cancer cells following exposure to a novel pH-responsive, gambogic acid-loaded micelle.
    Da M; Li S; Yang R; Jia Z; Ma Y; Qi F; Zhao J; Shen G; Chen D
    Nanotechnology; 2023 Dec; 35(11):. PubMed ID: 38081078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation.
    Tang X; Sun J; Ge T; Zhang K; Gui Q; Zhang S; Chen W
    Colloids Surf B Biointerfaces; 2018 Dec; 172():26-36. PubMed ID: 30125771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluronic F68-Linoleic Acid Nano-spheres Mediated Delivery of Gambogic Acid for Cancer Therapy.
    Fang X; Xu Y; Wang S; Wan J; He C; Chen M
    AAPS PharmSciTech; 2017 Jan; 18(1):147-155. PubMed ID: 26912357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.